Tadalafil 20mg + sildenafil 70mg + apomorphine 4mg, the highest apomorphine dose in our lineup, in one rapid-dissolve tablet, available only if prescribed after provider review.
From $115 for 6 doses
A PDE5 inhibitor, one of the most commonly prescribed ingredient classes for ED. It supports blood flow by blocking the PDE5 enzyme, and within the class it is known for its long duration window, which is why providers often choose it for as-needed formulas.
Also a PDE5 inhibitor, included here at a higher strength. It works through the same blood-flow pathway as tadalafil, and pairing the two covers both ingredients' profiles in a single tablet.
A different pathway entirely. Apomorphine acts on dopamine receptors in the central nervous system involved in sexual-response signaling, which is why providers may combine it with PDE5 inhibitors when a dual-pathway approach is appropriate.
Includes two PDE5 inhibitors plus apomorphine 4mg, which acts on dopamine receptors involved in sexual-response signaling.
An option a provider may consider when a patient has already tried other therapies and a combination approach is appropriate.
Designed to dissolve in the mouth without water and be taken as directed by your provider.
Prescribed only after a full review of your history and prior treatment response.
A 5-minute online health questionnaire — no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose adjustments and refills handled online.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment — provider will determine if appropriate →
Tadalafil 20mg + sildenafil 70mg in one rapid-dissolve tablet — combining sildenafil and tadalafil in a compounded formula when prescribed by a licensed provider.
Sildenafil 80mg paired with pycnogenol 50mg in a rapid-dissolve tablet, available when prescribed after provider review.
PT-141 (bremelanotide) is a subcutaneous injection that acts on melanocortin pathways in the central nervous system, prescribed when a licensed provider determines it is appropriate.